Navigation Links
Drug for bleeding disorder given to U.S soldiers

A drug that is used to treat bleeding disorders, like hemophilia, is being used to control bleeding in severely wounded U.S soldiers in Iraq. //

The drug Recombinant Activated Factor VIII has been proven in the past to cause serious complications in non-hemophiliacs. It can cause heart attacks, and strokes due to clot formation. Army doctors, in spite of the projected side effects, continue to prescribe it to control life threatening blood loss.

Jawed Fareed an expert in blood clotting therapeutics warns that this drug is very dangerous if not used cautiously. Doctors should refrain from prescribing it inappropriately, he cautioned.

Statistical data shows that over 1,000 critically wounded American soldiers have been treated so far with this drug. According to a report released by FDA, about 43 people might have died due to drug induced clot formation which results in strokes and heart attacks.

A Danish pharmaceutical company Novo Nordisk makes this drug which is accepted in the U.S to treat hemophiliacs. A single dose costs a whopping $6,000 in the U.S.
MST
'"/>




Page: 1

Related medicine news :

1. Antidepressants increase gastric bleeding
2. FDA approves new device to treat womens bleeding disorder
3. Antidepressants increase gastric bleeding
4. Depression medication can cause gastrointestinal bleedings
5. Potato powder to stop bleeding
6. Safest painkiller Ibuprofen found to cause severe GI bleeding
7. Eating disorder in Diabetic girls lead to eyesight damage.
8. Individuals with sleep related breathing disorders more prone to heart disease
9. Eating disorders are hereditary
10. Low testosterone levels lead to eating disorders
11. Eating disorder... a survey
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Drug for bleeding disorder given soldiers

(Date:1/22/2015)... 2015 VogueQueen is a seasoned and trusted ... many designers are thrilled to have it lead the wedding ... new collection of prom dresses for the global market. , ... strategic vision and he focuses on continuing the goal of ...
(Date:1/22/2015)... Blue Cross and Blue Shield of Minnesota (Blue ... means to “Live Fearless.” , The “Faces of ... stories about how they or someone they know has faced ... in the moment. By telling these types of stories through ...
(Date:1/22/2015)... Orlando, Florida (PRWEB) January 22, 2015 ... up today at the 2015 PGA Merchandise Show to ... lady and incredible female amateur golfer, Arlene McKitrick. The ... career female amateur golf tournament win. She won her ...
(Date:1/22/2015)... has released a new blog post explaining the main features ... , Auto insurance quotes help many drivers find the best ... call an agent or visit an agency for price information. ... http://autocarinsurancebest.com/ . , Every business who relies heavily on ...
(Date:1/22/2015)... 2015 Joan Lunden, award-winning American journalist, ... the upcoming 32nd Annual Miami Breast Cancer Conference ... Resource®, LLC (PER®) , shares that “a fast-growing, virulent” ... if she had not followed up her clean mammogram ...
Breaking Medicine News(10 mins):Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 5Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 6
... ... ... ... ...
... ... ... ... ...
... ... ... ... ...
... drug might help, scientists say , WEDNESDAY, March 10 ... details about molecular mechanisms associated with alcohol addiction and ... alcoholism. , The University of California, San Francisco researchers ... for nearly two months, followed by a few weeks ...
... Programs seem to be making progress against these ... -- Decades of vaccination and prevention efforts may have ... new report from the U.S. Centers for Disease Control ... of antibodies to various hepatitis strains. Antibodies are a ...
... Carolina State University have developed a new analytical method ... amounts of information, with applications in fields as diverse ... "The problem we address here is this: When faced ... determine which pieces of that information are relevant for ...
Cached Medicine News:Health News:Update: MedQuist Wins Contract with Detroit Medical Center for Emergency Medicine Transcription at Six Healthcare Organizations 2Health News:Update: MedQuist Wins Contract with Detroit Medical Center for Emergency Medicine Transcription at Six Healthcare Organizations 3Health News:Update: MedQuist Wins Contract with Detroit Medical Center for Emergency Medicine Transcription at Six Healthcare Organizations 4Health News:The NASCAR Foundation Announces 'The Big Five' Projects for NASCAR Day 2Health News:The NASCAR Foundation Announces 'The Big Five' Projects for NASCAR Day 3Health News:The NASCAR Foundation Announces 'The Big Five' Projects for NASCAR Day 4Health News:Visionworks(R) Provides Eye Care For Pittsburgh's Smiling Irish Eyes 2Health News:Visionworks(R) Provides Eye Care For Pittsburgh's Smiling Irish Eyes 3Health News:Alcoholics' Relapses Better Understood 2Health News:Vaccination, Prevention Is Beating Back Hepatitis 2Health News:Research streamlines data processing to solve problems more efficiently 2
(Date:1/23/2015)... Jan. 23, 2015   Leatt Corporation  (OTCQB: LEAT), a ... for all forms of sports, including extreme motor sports, ... announced today that the UISP Lega Motociclismo Lombardia, an ... riders to wear a neck brace during its racing ...
(Date:1/23/2015)... 2015 Tianyin Pharmaceutical Inc. (NYSE Amex: ... development and sale of patented biopharmaceutical medicine, modernized traditional ... (API) today announced the business and development progress at ... 1. Following the September 2014 JCM application (No. 51268) ...
(Date:1/22/2015)... 22, 2015 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or ... Omega-3 therapies for cardiovascular disease and overall health is pleased ... in 2014 and its outlook for 2015 from the CEO, ... We would like to take this opportunity to ...
Breaking Medicine Technology:Leatt Announces Neck Braces Now Required For Motocross/Minicross Racing In Italy 2Leatt Announces Neck Braces Now Required For Motocross/Minicross Racing In Italy 3TPI's JCM Updates on Import Registration for International Clients 2TPI's JCM Updates on Import Registration for International Clients 3TPI's JCM Updates on Import Registration for International Clients 4Pivotal Therapeutics: Year in Review and CEO Update 2Pivotal Therapeutics: Year in Review and CEO Update 3Pivotal Therapeutics: Year in Review and CEO Update 4Pivotal Therapeutics: Year in Review and CEO Update 5Pivotal Therapeutics: Year in Review and CEO Update 6Pivotal Therapeutics: Year in Review and CEO Update 7
... , , , , ... , THE WOODLANDS, Texas, July 21 ... biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, ... for Orphan Medical Products (COMP) of the European Medicines Agency (EMEA) for ...
... , TOKYO, July 21 R-Tech Ueno, Ltd. ... on the new compound RK-023 that is being developed by our ... see the note below) has been completed. , ... of a patch test (open, closed, photo-patch test), single-dose study and ...
Cached Medicine Technology:Lexicon's Drug Candidate LX1032 for Carcinoid Syndrome Receives Orphan Drug Designation From EMEA 2Lexicon's Drug Candidate LX1032 for Carcinoid Syndrome Receives Orphan Drug Designation From EMEA 3Lexicon's Drug Candidate LX1032 for Carcinoid Syndrome Receives Orphan Drug Designation From EMEA 4R-Tech Ueno, Ltd. Completes Phase 1 Clinical Study on RK-023 2R-Tech Ueno, Ltd. Completes Phase 1 Clinical Study on RK-023 3